Jin Biotech Reports Over 1000% Increase in Net Loss
[Asia Economy Reporter Ji Yeon-jin] Jin Biotech announced on the 3rd that its sales revenue last year reached 62.3 billion KRW, an increase of 7.03% compared to the previous year. Operating profit decreased by 88.81% to approximately 900 million KRW, and net loss for the period expanded by 1031% to 300 million KRW.
Hot Picks Today
![[Exclusive] "What? I Used It for Fried Eggs and Kimchi Pancakes, but It Wasn't Edible?"... Raw Pork Lard Supplied to Department Stores, Causing Stir](https://cwcontent.asiae.co.kr/asiaresize/93/2026042216151436513_1776842114.png)
[Exclusive] "What? I Used It for Fried Eggs and...
- [Report] "Professionals in Their 30s and 40s With at Least 2 Billion Won in Cash...
- "375 Won Per Share" SK hynix to Pay 26.58 Billion Won Cash Dividend
- No More Updates on 'Star' Wolf Neugoo for Now... Was the Pressure from Fans Over...
- "Chairman Chey Tae-won's Warning Comes True"... Laptop Prices Already Up 1 Milli...
The company decided to pay a cash dividend of 30 KRW per common share.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
